Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP851657.RAFeQDoar5W7yK9PlS3ZBilZoFUJp8YvD6os4oCjLzmeI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP851657.RAFeQDoar5W7yK9PlS3ZBilZoFUJp8YvD6os4oCjLzmeI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP851657.RAFeQDoar5W7yK9PlS3ZBilZoFUJp8YvD6os4oCjLzmeI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP851657.RAFeQDoar5W7yK9PlS3ZBilZoFUJp8YvD6os4oCjLzmeI130_provenance.
- NP851657.RAFeQDoar5W7yK9PlS3ZBilZoFUJp8YvD6os4oCjLzmeI130_assertion description "[As a result, we investigated the possible role of key point mutations in Tyr from IL6ST exon 17 that encode for the catalytic domain of gp130, and of its respective activators (IL-6 family member cytokines) in human gastric cancer initiation and development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851657.RAFeQDoar5W7yK9PlS3ZBilZoFUJp8YvD6os4oCjLzmeI130_provenance.
- NP851657.RAFeQDoar5W7yK9PlS3ZBilZoFUJp8YvD6os4oCjLzmeI130_assertion evidence source_evidence_literature NP851657.RAFeQDoar5W7yK9PlS3ZBilZoFUJp8YvD6os4oCjLzmeI130_provenance.
- NP851657.RAFeQDoar5W7yK9PlS3ZBilZoFUJp8YvD6os4oCjLzmeI130_assertion SIO_000772 22457856 NP851657.RAFeQDoar5W7yK9PlS3ZBilZoFUJp8YvD6os4oCjLzmeI130_provenance.
- NP851657.RAFeQDoar5W7yK9PlS3ZBilZoFUJp8YvD6os4oCjLzmeI130_assertion wasDerivedFrom befree-20140225 NP851657.RAFeQDoar5W7yK9PlS3ZBilZoFUJp8YvD6os4oCjLzmeI130_provenance.
- NP851657.RAFeQDoar5W7yK9PlS3ZBilZoFUJp8YvD6os4oCjLzmeI130_assertion wasGeneratedBy ECO_0000203 NP851657.RAFeQDoar5W7yK9PlS3ZBilZoFUJp8YvD6os4oCjLzmeI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP851657.RAFeQDoar5W7yK9PlS3ZBilZoFUJp8YvD6os4oCjLzmeI130_provenance.